Biochips Global Analysis & Forecast to 2023 Market Research Report Biochips Market - Global Industry Analysis, Size,

Biochips Market - Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2015 – 2023
This market research study analyzes the biochips market on global basis and provides estimates in
terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the
industry and analyzes their impact through the forecast period. Moreover, it highlights the significant
opportunities for market growth in the next eight years.
Biochips are a collection of microarrays which are arranged on a solid substrate that enables
numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips
are designed to function in biological environments and are capable of detecting and measuring a
large number of biomarkers and perform complex biochemical reactions simultaneously in a very short
span of time. There have been considerable advancements in the biotechnology industry on account
of the increasing application of biochips. In addition, biochips are largely used for research in drug
discovery and development, genomics, proteomics, and molecular diagnostics. Biochips help in
analyzing organic molecules related to living organisms. Therefore, they help in detecting gene
sequences, environmental pollutants, airborne toxins, and other biochemical constituents.
This 110 page report gives readers a comprehensive overview of the Biochips market Browse through
09 data tables and 40 figures to unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/biochips-market.html
Increasing application of biochips in the medical sector for cancer treatment, drug research, and
diagnostics is one of the major factors driving the growth of the global biochips market. In addition,
factors such as availability of molecular information, automation of biochemical processes through the
use of biochips and application of biochips for gene and protein identification are set to drive the global
biochips market.
The use of biochips has brought about a transition in the field of drug discovery and research. Biochips
have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can
easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time.
Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise
grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which
bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled
with the need for identifying gene sequences and proteins in human beings is driving the biochips
market. Conventional gene and protein sequencing methods cannot provide qualitative output and are
ineffective whereas biochips are extremely effective and produce accurate gene sequencing results
in a very short span of time.
Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical
expenditure coupled with economic reforms in major developing countries has been able to bolster
the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and
are expected to provide huge opportunities to the global biochips manufacturers.